These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 13120049)

  • 21. [Clinical experiences in the obsterical and gynecological field with an orally active enolic derivative of progesterone].
    GIANAROLI L
    Minerva Ginecol; 1961 Jun; 13():636-9. PubMed ID: 13705004
    [No Abstract]   [Full Text] [Related]  

  • 22. Hormonal treatment of menstruation disorders with perorally effective gestagens.
    HERRMANN U; ARN H; ALDER A
    Schweiz Med Wochenschr; 1958 Dec; 88(50):1257-60. PubMed ID: 13624652
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic pseudopregnancy].
    HOFHANSL W
    Zentralbl Gynakol; 1961 Jan; 83():113-9. PubMed ID: 13715081
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of neurosteroids in catamenial epilepsy.
    Reddy DS
    Epilepsy Res; 2004 Dec; 62(2-3):99-118. PubMed ID: 15579299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. X-ray therapy in menstrual disorders and infertility.
    ASHERMAN JG
    Harefuah; 1957 Apr; 52(7):163-6. PubMed ID: 13428175
    [No Abstract]   [Full Text] [Related]  

  • 26. [A new substance of prolonged progestational activity: 17 alpha-hydroxyprogesterone caproate].
    ANDREOLI C
    Minerva Med; 1958 Jun; 49(47):2340-2. PubMed ID: 13565662
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use and administration of sex hormones in menstrual cyclic abnormalities].
    GARCIA BARBOSA JL
    Ginecol Obstet Mex; 1952; 7(4):307-20. PubMed ID: 14955104
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of functional bleeding with 17 alpha-hydroxyprogesterone capronate; indication and limitations of treatment].
    ZORN H
    Geburtshilfe Frauenheilkd; 1958 Jul; 18(7):924-33. PubMed ID: 13574404
    [No Abstract]   [Full Text] [Related]  

  • 29. [Determination of progesterone in the blood. Technic and use in the exploration of the normal and pathological menstrual cycle].
    HERVE R; SERGENT P
    Gynecol Obstet (Paris); 1961; 60():55-75. PubMed ID: 13713840
    [No Abstract]   [Full Text] [Related]  

  • 30. [Interval of action and time of onset and duration of bleeding after the administration of the depot gestagen, 17-alpha-hydroxyprogesterone caproate].
    RAUSCHER H; KOFLER E
    Geburtshilfe Frauenheilkd; 1958 May; 18(5):766-70. PubMed ID: 13548486
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hormone therapy of functional menstrual disorders].
    PAHLSSON NE
    Nord Med; 1953 Apr; 49(15):527-32. PubMed ID: 13072891
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical effects of 6-alpha-methyl-17-alpha-hydroxy-progesterone acetate in intramuscular administration].
    ONETTO E
    Rev Med Chil; 1961 Aug; 89():576-84. PubMed ID: 14482031
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of delayed desquamation of the endometrium].
    LLEO CARRERA J
    Tokoginecol Pract; 1960; 19():301-4. PubMed ID: 14417696
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical use of a new oral progesterone: 6, 17 alpha-dimethyl-6-dehydroprogesterone].
    Del Corral F; Artuz A; Salcedo CA
    Rev Colomb Obstet Ginecol; 1967; 18(1):41-51. PubMed ID: 5614785
    [No Abstract]   [Full Text] [Related]  

  • 35. [17-Methyl-19-nortestosterone in menstrual disorders].
    ARGONZ J; WAIS S; GRINBERG R; ARGONZ JJ
    Sem Med; 1958 Dec; 113(23):1041-5. PubMed ID: 13646821
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of menstrual abnormalities.
    MENGERT WF
    Cinci J Med; 1952 Jan; 33(1):2-7, contd. PubMed ID: 14905557
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hormonal treatment of polymenorrhea].
    BOSCH LR
    Sem Med; 1961 Aug; 119():754-5. PubMed ID: 13871534
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of ethylnortestosterone and ethinylnortestosterone in various menstrual disorders].
    WASCHKE G
    Zentralbl Gynakol; 1957 Aug; 79(31):1199-210. PubMed ID: 13486882
    [No Abstract]   [Full Text] [Related]  

  • 39. [Implantation of pituitary gland in menstrual disorders. I..].
    ROEMER H; VOLLMER E
    Medizinische; 1954 Aug; 35():1142-7; contd. PubMed ID: 13213592
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of autonomic disorders connected with the menstrual cycle with venoplant].
    FASSLER V
    Med Monatsschr; 1956 Dec; 10(12):793-4. PubMed ID: 13399776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.